Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APGE

Apogee Therapeutics Inc

May 01 • 09:49AM ET

82.40

-0.49 -0.59 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: VRTX REGN BMRN SRPT IONS ALNY QURE CRSP NTLA SGMO

| Held by: VTI XBI IWM TCAF VXF IWO IBB SCHA VTWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.21	Insider Own	29.97%	Shs Outstand	54.91M	Perf Week	-3.74%
Market Cap	6.21B	Forward P/E	-	EPS next Y	-5.58	Insider Trans	-8.11%	Shs Float	53.75M	Perf Month	-2.18%
Enterprise Value	5.49B	PEG	-	EPS next Q	-1.09	Inst Own	94.61%	Short Float	17.80%	Perf Quarter	25.79%
Income	-255.84M	P/S	-	EPS this Y	-10.29%	Inst Trans	23.60%	Short Ratio	10.19	Perf Half Y	47.94%
Sales	0.00M	P/B	6.24	EPS next Y	-19.79%	ROA	-30.26%	Short Interest	9.57M	Perf YTD	9.17%
Book/sh	13.21	P/C	8.50	EPS next 5Y	-16.66%	ROE	-31.57%	52W High	95.32 -13.54%	Perf Year	110.22%
Cash/sh	9.69	P/FCF	-	EPS past 3/5Y	-75.11% -	ROIC	-28.14%	52W Low	34.34 139.97%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.41% 3.96%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-30.45%	Oper. Margin	-	ATR (14)	3.70	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	26.57	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.16	Recom	1.24
Dividend Gr. 3/5Y	- -	Current Ratio	26.57	EPS Q/Q	9.17%	SMA20	-5.06%	Beta	0.69	Target Price	118.31
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	4.51%	Rel Volume	0.29	Prev Close	82.89
Employees	261	LT Debt/Eq	0.01	Earnings	Mar 02 BMO	SMA200	33.24%	Avg Volume	938.85K	Price	82.40
IPO	Jul 14, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.10% -	Trades		Volume	25,906	Change	-0.59%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)